Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer

As the current efficacy of oncolytic viruses (OVs) as monotherapy is limited, exploration of OVs as part of a broader immunotherapeutic treatment strategy for cancer is necessary. Here, we investigated the ability for immune checkpoint blockade to enhance the efficacy of oncolytic reovirus (RV) for...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostafa, Ahmed A., Meyers, Daniel E., Thirukkumaran, Chandini M., Liu, Peter J., Gratton, Kathy, Spurrell, Jason, Shi, Qiao, Thakur, Satbir, Morris, Don G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025420/
https://www.ncbi.nlm.nih.gov/pubmed/29914097
http://dx.doi.org/10.3390/cancers10060205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025420/
https://www.ncbi.nlm.nih.gov/pubmed/29914097
http://dx.doi.org/10.3390/cancers10060205

Ejemplares similares